There is no standard blood test that can diagnose fibromyalgia. The condition is diagnosed based on your symptoms, specifically widespread pain lasting at least three months combined with fatigue, sleep problems, and cognitive difficulties. While one commercial blood test does exist and some biomarker research is underway, neither has changed how doctors actually diagnose or treat the condition in practice.
How Fibromyalgia Is Actually Diagnosed
Fibromyalgia is diagnosed using clinical criteria, meaning your doctor evaluates your symptom pattern rather than relying on a lab result. The most widely used framework, updated by the American College of Rheumatology in 2016, requires three things: generalized pain in at least four of five body regions, symptoms lasting at least three months, and scores above certain thresholds on two scales that measure how widespread the pain is and how severe your fatigue, unrefreshing sleep, and cognitive symptoms (“fibro fog”) are.
A newer set of criteria from 2019 takes a slightly different approach. It maps pain across nine specific body sites (head, chest, abdomen, upper back, lower back, and each arm and leg) and requires at least six of those sites to be affected, along with moderate to severe sleep problems or fatigue, for at least three months.
Both frameworks rely entirely on what you report about your own body. There’s no imaging scan, nerve test, or blood draw that confirms the diagnosis. This can feel frustrating, especially if you’ve been dealing with symptoms for months or years and want something concrete. But the clinical criteria are well-validated and widely accepted. A diagnosis based on them is real and legitimate.
The FM/a Test: What It Actually Shows
There is one commercially available blood test marketed for fibromyalgia, called the FM/a Test. It measures how your white blood cells produce certain immune signaling proteins (cytokines) when stimulated in a lab. People with fibromyalgia tend to produce these proteins in a different pattern than healthy people, and the test generates a score based on four of those proteins.
In the study used to validate it, the test had a sensitivity of 93% and a specificity of 89% when comparing fibromyalgia patients to healthy controls. Those numbers sound impressive, but there’s an important catch: they only tell you the test can distinguish fibromyalgia from being completely healthy. When researchers compared fibromyalgia patients to people with rheumatoid arthritis or lupus, conditions that share some overlapping symptoms, the specificity dropped to 70%. The false-positive rate in lupus and rheumatoid arthritis patients was around 29% to 31%.
The bigger problem is that the test has never been studied in the population that would actually use it: people who walk into a doctor’s office with pain and fatigue and don’t yet have a diagnosis. No research has shown that the FM/a Test changes how doctors manage fibromyalgia or improves outcomes for patients. It has not received FDA approval as a diagnostic tool, and most insurance plans do not cover it. If you pay out of pocket, expect to spend several hundred dollars, with some panels priced around $375.
Blood Tests Your Doctor May Order Anyway
Even though no blood test diagnoses fibromyalgia, your doctor will likely order bloodwork during the evaluation. The purpose is to rule out other conditions that can cause similar symptoms. Several common mimics show up clearly on standard lab tests:
- Complete blood count (CBC) checks for anemia and signs of infection, both of which can cause widespread fatigue and achiness.
- Erythrocyte sedimentation rate (ESR) or C-reactive protein (CRP) measures inflammation in the body. Elevated levels point toward inflammatory conditions like polymyalgia rheumatica or rheumatoid arthritis rather than fibromyalgia, which does not cause measurable inflammation.
- Thyroid hormone tests screen for underactive or overactive thyroid, which can produce fatigue and muscle soreness that closely resembles fibromyalgia.
- Blood calcium levels identify abnormalities that can cause muscle cramps, which might overlap with fibromyalgia-like pain. A high calcium level can also signal an overactive parathyroid gland.
These tests are not fibromyalgia tests. They’re used to make sure something else isn’t causing your symptoms. If your results come back normal and your symptom pattern fits the clinical criteria, that combination is what supports the diagnosis. Normal bloodwork in the context of widespread pain, fatigue, and cognitive symptoms is itself a meaningful finding.
Biomarker Research in Early Stages
Scientists are actively looking for biological signatures in the blood that could one day serve as a fibromyalgia test. One promising area involves microRNAs, tiny molecules that help regulate gene activity. A 2025 study found that a combination of several microRNAs in whole blood could distinguish fibromyalgia patients from controls with reasonable accuracy, and some of these molecules correlated with pain severity. Fragments of another type of RNA (transfer RNA) also showed potential as markers.
These findings are genuinely interesting, but they’re still in the discovery phase. The accuracy levels are not yet high enough for a standalone diagnostic test, and none of these markers have been validated in large, diverse populations or tested in real clinical settings where patients show up with undiagnosed pain. Translating a promising lab finding into a reliable, commercially available test typically takes years of additional study.
What This Means for Getting a Diagnosis
If you’re experiencing widespread pain, crushing fatigue, and trouble thinking clearly, the path to a fibromyalgia diagnosis runs through a thorough clinical evaluation, not a single blood draw. That evaluation includes a detailed conversation about where you hurt, how long it’s been going on, how you’re sleeping, and how your thinking and memory have been affected. It also includes bloodwork to rule out conditions that look similar but have different treatments.
The lack of a definitive blood test doesn’t mean the diagnosis is uncertain or subjective. The clinical criteria are specific and structured. A doctor who is familiar with fibromyalgia can often reach a confident diagnosis in one or two visits, provided you’ve been experiencing symptoms for at least three months. If your primary care doctor seems dismissive or unfamiliar with the condition, a rheumatologist or a pain specialist may be a better fit for the initial evaluation.